1. Home
  2. WDFC vs GLPG Comparison

WDFC vs GLPG Comparison

Compare WDFC & GLPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo WD-40 Company

WDFC

WD-40 Company

HOLD

Current Price

$225.43

Market Cap

2.6B

Sector

Industrials

ML Signal

HOLD

Logo Galapagos NV

GLPG

Galapagos NV

HOLD

Current Price

$34.15

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WDFC
GLPG
Founded
1953
1999
Country
United States
Belgium
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.2B
IPO Year
N/A
2005

Fundamental Metrics

Financial Performance
Metric
WDFC
GLPG
Price
$225.43
$34.15
Analyst Decision
Strong Buy
Hold
Analyst Count
1
4
Target Price
$300.00
$31.33
AVG Volume (30 Days)
208.9K
122.2K
Earning Date
01-08-2026
02-23-2026
Dividend Yield
1.81%
N/A
EPS Growth
26.07
N/A
EPS
6.58
N/A
Revenue
$620,913,000.00
$336,643,201.00
Revenue This Year
$7.09
$1.76
Revenue Next Year
$6.02
$0.49
P/E Ratio
$34.32
N/A
Revenue Growth
2.86
10.31
52 Week Low
$175.38
$22.36
52 Week High
$253.48
$37.78

Technical Indicators

Market Signals
Indicator
WDFC
GLPG
Relative Strength Index (RSI) 75.11 61.40
Support Level $199.43 $34.18
Resistance Level $206.90 $35.06
Average True Range (ATR) 6.85 0.66
MACD 2.21 0.03
Stochastic Oscillator 100.00 71.67

Price Performance

Historical Comparison
WDFC
GLPG

About WDFC WD-40 Company

WD-40 Co is a global marketing organization focused on developing and selling products that solve maintenance and cleaning problems internationally. It offers two product groups: maintenance products, including the flagship WD-40 Multi-Use Product, which serves as a lubricant, rust preventative, penetrant, and moisture displacer, marketed globally; and homecare and cleaning products, mainly sold in North America, the UK, and Australia. The company distributes its products through hardware stores, automotive parts outlets, industrial suppliers, mass retailers, online platforms, and specialty retailers across the Americas, EIMEA, and Asia-Pacific, with the majority of revenue generated in the Americas.

About GLPG Galapagos NV

Galapagos NV is a fully integrated biotechnology company with operations in Europe and the United States, dedicated to developing medicines focusing on oncology and immunology. The group focuses on unmet medical needs, it synergizes compelling science, technology, and collaborative approaches to create a deep pipeline of medicines. Its clinical pipeline includes: GLPG5101, a CD19 CAR-T product candidate decentralized manufactured, currently in Phase 1/2 in rrNHL; GLPG5301, a BCMA CAR-T product candidate decentralized manufactured, currently in Phase 1 in rrMM; and GLPG3667, a TYK2 inhibitor currently in Phase 2 clinical trial in DM and SLE. It derives maximum revenue from the United States of America.

Share on Social Networks: